Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon

Life expectancy lower among SAVR patients than the general public

Should patients be undergoing SAVR earlier? Is poor follow-up care partially to blame? 

Thumbnail

TMVR with transfemoral access a 'promising option,’ early data suggest

Researchers reported at TCT 2021 that survival was 100% after 30 days.

Thumbnail

5 years later, TAVR still delivering strong results for intermediate-risk patients

Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years. 

Thumbnail

TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms

The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.

Thumbnail

Disabilities fairly common among adults with congenital heart defects

The study's authors said that policies should be put in place to provide better support for these individuals. 

Thumbnail

LAAC reduces stroke risk among patients with HCM and AFib

The team behind the new pilot study said additional research is still necessary to confirm its findings. 

Two-year outcomes highlight the value of TMVR for patients with severe MR

Patients continue to see the benefits of transcatheter mitral valve replacement a full two years after treatment.

Thumbnail

Mitral valve prolapse during pregnancy linked to higher risk of cardiac complications

MVP also appears to increase the risk of certain problems during childbirth. 

Displaying 521 - 528 of 879
Design by Adaptive Theme